Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12688/f1000research.9916.1 http://scihub22266oqcxt.onion/10.12688/f1000research.9916.1 C5414822!5414822!28529721     free     free     free       F1000Res 2017 ; 6 (ä): ä Nephropedia Template TP {{tp|p=28529721|t=2017. The impact of antihypertensives on kidney disease |pdf=|usr=}}{{28529721}} gab.com Text The impact of antihypertensives on kidney disease JO: F1000Res http://www.kidney.de/pget.php?&tw=1&pmid=28529721 #FOAvip Arterial hypertension and chronic kidney disease (CKD) are intimately related. The control of blood pressure (BP) levels is strongly recommended in patients with CKD in order to protect the kidney against the accompanying elevation in global cardiovascular (CV) risk. Actually, the goal BP in patients with CKD involves attaining values <140/90 mmHg except if albuminuria is present. In this case, it is often recommended to attain values <130/80 mmHg, although some guidelines still recommend <140/90 mmHg. Strict BP control to values of systolic BP around 120 mmHg was recently shown to be safe in CKD according to data from the SPRINT trial, albeit more data confirming this benefit are required. Usually, combination therapy initiated with an angiotensin receptor blocker (ARB) or angiotensin-converting enzyme inhibitor (ACEi) and commonly followed by the addition of a calcium channel blocker and a diuretic is needed. Further studies are required as well as new drugs in particular after the positive data obtained from new oral anti-diabetic drugs. Twit Text FOAVip The impact of antihypertensives on kidney disease ????F1000Res http://www.kidney.de/pget.php?&tw=1&pmid=28529721 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28529721 #FOAvip English Wikipedia <ref>{{Cite pmid|28529721}}</ref> The impact of antihypertensives on kidney disease #MMPMID28529721 Marquez DF; Ruiz-Hurtado G; Ruilope L F1000Res 2017[]; 6 (ä): ä PMID28529721show ga Arterial hypertension and chronic kidney disease (CKD) are intimately related. The control of blood pressure (BP) levels is strongly recommended in patients with CKD in order to protect the kidney against the accompanying elevation in global cardiovascular (CV) risk. Actually, the goal BP in patients with CKD involves attaining values <140/90 mmHg except if albuminuria is present. In this case, it is often recommended to attain values <130/80 mmHg, although some guidelines still recommend <140/90 mmHg. Strict BP control to values of systolic BP around 120 mmHg was recently shown to be safe in CKD according to data from the SPRINT trial, albeit more data confirming this benefit are required. Usually, combination therapy initiated with an angiotensin receptor blocker (ARB) or angiotensin-converting enzyme inhibitor (ACEi) and commonly followed by the addition of a calcium channel blocker and a diuretic is needed. Further studies are required as well as new drugs in particular after the positive data obtained from new oral anti-diabetic drugs. äThe impact of antihypertensives on kidney disease (epmc).pdf DeepDyve Pubget Overpricing